Remove Exercise Remove Pacemaker Remove Quality of Life
article thumbnail

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

DAIC

RELIEVE-HF failed to meet its primary efficacy endpoint and did not reduce heart failure events or improve quality of life in heart failure patients with a preserved ejection fraction (HFpEF). For more information: www.corviamedical.com If you enjoy this content, please share it with a colleague

article thumbnail

Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart Failure

Circulation

BACKGROUND:Despite advances in medical and cardiac resynchronization therapy (CRT), individuals with chronic congestive heart failure (CHF) have persistent symptoms, including exercise intolerance. Optimizing cardio-locomotor coupling may increase stroke volume and skeletal muscle perfusion as previously shown in healthy runners.

article thumbnail

Resynchronising the Heart in Heart Failure

Dr. Sanjay Gupta

Today’s vlog is on the subject of heart failure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heart failure. You can download this script as a Hindi translation here. What is heart failure?

article thumbnail

Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP?HF II trial

European Journal of Heart Failure

Patients with more severe obesity were more likely to have responder characteristics for atrial shunt therapy (fewer pacemakers and lower exercise pulmonary vascular resistance [PVR]). Pulmonary vascular resistance at rest and exercise decreased with higher BMI. Overall, 60.9% of patients had BMI ≥30 kg/m 2.

article thumbnail

Nerve Stimulation Plus Intense Rehab May Improve Arm and Hand Function After Stroke

DAIC

“The recovery of arm and hand function after a stroke often stalls or even declines, leaving many patients with chronic motor deficits that limit their independence and quality of life. The in-clinic therapy was followed by a three-month home exercise program for both groups. Kimberley , Ph.D.,

Stroke 98
article thumbnail

The Management of Chronic Disease

Dr. Sanjay Gupta

Pharmacological treatments: These can be divided into 2 groups Medications that improve quality of life (usually by relieving symptoms) and medications that can prolong life. Medications that improve quality of life in heart failure for example include diuretics.